Copyright Reports & Markets. All rights reserved.

Global Serum (Blood) Market Insights, Forecast to 2025

Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Serum (Blood) Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Serum (Blood) Market Size Growth Rate by Product
      • 1.4.2 Bovine Serum
      • 1.4.3 FBS
    • 1.5 Market by End User
      • 1.5.1 Global Serum (Blood) Market Size Growth Rate by End User
      • 1.5.2 Biological Products
      • 1.5.3 Research
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Serum (Blood) Market Size
      • 2.1.1 Global Serum (Blood) Revenue 2014-2025
      • 2.1.2 Global Serum (Blood) Sales 2014-2025
    • 2.2 Serum (Blood) Growth Rate by Regions
      • 2.2.1 Global Serum (Blood) Sales by Regions
      • 2.2.2 Global Serum (Blood) Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Serum (Blood) Sales by Manufacturers
      • 3.1.1 Serum (Blood) Sales by Manufacturers
      • 3.1.2 Serum (Blood) Sales Market Share by Manufacturers
      • 3.1.3 Global Serum (Blood) Market Concentration Ratio (CR5 and HHI)
    • 3.2 Serum (Blood) Revenue by Manufacturers
      • 3.2.1 Serum (Blood) Revenue by Manufacturers (2014-2019)
      • 3.2.2 Serum (Blood) Revenue Share by Manufacturers (2014-2019)
    • 3.3 Serum (Blood) Price by Manufacturers
    • 3.4 Serum (Blood) Manufacturing Base Distribution, Product Types
      • 3.4.1 Serum (Blood) Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Serum (Blood) Product Type
      • 3.4.3 Date of International Manufacturers Enter into Serum (Blood) Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Serum (Blood) Sales by Product
    • 4.2 Global Serum (Blood) Revenue by Product
    • 4.3 Serum (Blood) Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Serum (Blood) Breakdown Data by End User

    6 North America

    • 6.1 North America Serum (Blood) by Countries
      • 6.1.1 North America Serum (Blood) Sales by Countries
      • 6.1.2 North America Serum (Blood) Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Serum (Blood) by Product
    • 6.3 North America Serum (Blood) by End User

    7 Europe

    • 7.1 Europe Serum (Blood) by Countries
      • 7.1.1 Europe Serum (Blood) Sales by Countries
      • 7.1.2 Europe Serum (Blood) Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Serum (Blood) by Product
    • 7.3 Europe Serum (Blood) by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Serum (Blood) by Countries
      • 8.1.1 Asia Pacific Serum (Blood) Sales by Countries
      • 8.1.2 Asia Pacific Serum (Blood) Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Serum (Blood) by Product
    • 8.3 Asia Pacific Serum (Blood) by End User

    9 Central & South America

    • 9.1 Central & South America Serum (Blood) by Countries
      • 9.1.1 Central & South America Serum (Blood) Sales by Countries
      • 9.1.2 Central & South America Serum (Blood) Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Serum (Blood) by Product
    • 9.3 Central & South America Serum (Blood) by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Serum (Blood) by Countries
      • 10.1.1 Middle East and Africa Serum (Blood) Sales by Countries
      • 10.1.2 Middle East and Africa Serum (Blood) Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Serum (Blood) by Product
    • 10.3 Middle East and Africa Serum (Blood) by End User

    11 Company Profiles

    • 11.1 Thermo Fisher (Life-Tech)
      • 11.1.1 Thermo Fisher (Life-Tech) Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Thermo Fisher (Life-Tech) Serum (Blood) Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Thermo Fisher (Life-Tech) Serum (Blood) Products Offered
      • 11.1.5 Thermo Fisher (Life-Tech) Recent Development
    • 11.2 Sigma-Aldrich
      • 11.2.1 Sigma-Aldrich Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Sigma-Aldrich Serum (Blood) Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Sigma-Aldrich Serum (Blood) Products Offered
      • 11.2.5 Sigma-Aldrich Recent Development
    • 11.3 Merck
      • 11.3.1 Merck Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Merck Serum (Blood) Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Merck Serum (Blood) Products Offered
      • 11.3.5 Merck Recent Development
    • 11.4 Corning
      • 11.4.1 Corning Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Corning Serum (Blood) Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Corning Serum (Blood) Products Offered
      • 11.4.5 Corning Recent Development
    • 11.5 Bovogen
      • 11.5.1 Bovogen Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Bovogen Serum (Blood) Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Bovogen Serum (Blood) Products Offered
      • 11.5.5 Bovogen Recent Development
    • 11.6 Moregate Biotech
      • 11.6.1 Moregate Biotech Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Moregate Biotech Serum (Blood) Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Moregate Biotech Serum (Blood) Products Offered
      • 11.6.5 Moregate Biotech Recent Development
    • 11.7 Biowest
      • 11.7.1 Biowest Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Biowest Serum (Blood) Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Biowest Serum (Blood) Products Offered
      • 11.7.5 Biowest Recent Development
    • 11.8 Gemini
      • 11.8.1 Gemini Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Gemini Serum (Blood) Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Gemini Serum (Blood) Products Offered
      • 11.8.5 Gemini Recent Development
    • 11.9 Bioind
      • 11.9.1 Bioind Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Bioind Serum (Blood) Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Bioind Serum (Blood) Products Offered
      • 11.9.5 Bioind Recent Development
    • 11.10 Tissue Culture Biologicals
      • 11.10.1 Tissue Culture Biologicals Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 Tissue Culture Biologicals Serum (Blood) Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 Tissue Culture Biologicals Serum (Blood) Products Offered
      • 11.10.5 Tissue Culture Biologicals Recent Development
    • 11.11 Animal Technologies
    • 11.12 South Pacific Sera
    • 11.13 Lanzhou Minhai
    • 11.14 Changchun Xinuo
    • 11.15 Wuhan Sanli

    12 Future Forecast

    • 12.1 Serum (Blood) Market Forecast by Regions
      • 12.1.1 Global Serum (Blood) Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Serum (Blood) Revenue Forecast by Regions 2019-2025
    • 12.2 Serum (Blood) Market Forecast by Product
      • 12.2.1 Global Serum (Blood) Sales Forecast by Product 2019-2025
      • 12.2.2 Global Serum (Blood) Revenue Forecast by Product 2019-2025
    • 12.3 Serum (Blood) Market Forecast by End User
    • 12.4 North America Serum (Blood) Forecast
    • 12.5 Europe Serum (Blood) Forecast
    • 12.6 Asia Pacific Serum (Blood) Forecast
    • 12.7 Central & South America Serum (Blood) Forecast
    • 12.8 Middle East and Africa Serum (Blood) Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Serum (Blood) Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      The global Serum (Blood) market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Serum (Blood) market based on company, product type, end user and key regions.

      This report studies the global market size of Serum (Blood) in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Serum (Blood) in these regions.
      This research report categorizes the global Serum (Blood) market by top players/brands, region, type and end user. This report also studies the global Serum (Blood) market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Thermo Fisher (Life-Tech)
      Sigma-Aldrich
      Merck
      Corning
      Bovogen
      Moregate Biotech
      Biowest
      Gemini
      Bioind
      Tissue Culture Biologicals
      Animal Technologies
      South Pacific Sera
      Lanzhou Minhai
      Changchun Xinuo
      Wuhan Sanli

      Market size by Product
      Bovine Serum
      FBS
      Market size by End User
      Biological Products
      Research

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Serum (Blood) market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Serum (Blood) market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Serum (Blood) companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Serum (Blood) submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Serum (Blood) are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Serum (Blood) market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now